TrialBMC cancer2025

Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial.

Zijing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.